Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

AFM-13 acts according to expectations in preclinical studies

April 25, 2008

PharmaGap reports results from animal studies of PhG-alpha1 for cancer

April 25, 2008

FDA approves Calando's IND application for siRNA nanoparticle therapeutic CALAA-01

April 24, 2008

AEterna Zentaris develops new cytotoxic conjugate, AEZS-125

April 24, 2008

MI-219 displays preclinical anticancer activity

April 24, 2008

Novel inhibitor of tyrosine kinases shows antitumor activity in preclinical models

April 24, 2008

Hsp90 inhibitors demonstrate antitumor effects in preclinical studies

April 24, 2008

Lorus Therapeutics to examine new administration route for LOR-2040

April 23, 2008

SNS-314 induces tumor growth inhibition in xenograft models

April 23, 2008

BMS-753493 cytotoxic in folate receptor-positive human tumor cells

April 23, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...